Will this batch be potent or subpotent
Important tests for compounded GLP-1 injectable medications include: potency testing via HPLC (verifying correct active ingredient concentration), sterility testing per USP 71 (confirming no microbial contamination), endotoxin testing via LAL per USP 85 (ensuring pyrogen-free), pH testing, particulate matter testing per USP 788, and container closure integrity testing
For me, it was an opportunity of a life time
In 5 years, obesity drugs went from 15% weight loss (Wegovy) to 29% (Retatrutide)
It was apparent, however, that agonists diverged both in internalization and recycling capacity, both of which contribute to the net changes to GLP-1R PM residence over time
But those results did not happen by accident